Unknown

Dataset Information

Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy.


ABSTRACT:

Background

After breast-conserving radiation therapy most patients experience acute skin toxicity to some degree. This may impair patients' quality of life, cause pain and discomfort. In this study, we investigated treatment and patient-related factors, including genetic polymorphisms, that can modify the risk for severe radiation-induced skin toxicity in breast cancer patients.

Methods

We studied 377 patients treated at Ghent University Hospital and at ST.-Elisabeth Clinic and Maternity in Namur, with adjuvant intensity modulated radiotherapy (IMRT) after breast-conserving surgery for breast cancer. Women were treated in a prone or supine position with normofractionated (25 × 2 Gy) or hypofractionated (15 × 2.67 Gy) IMRT alone or in combination with other adjuvant therapies

SUBMITTER: De Langhe S 

PROVIDER: S-EPMC4192342 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature